Join to View Full Profile
44 Binney StDana Farber Cancer InstituteBoston, MA 02115
Phone+1 617-632-2112
Fax+1 617-632-5757
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alan Dandrea, MD is a pediatric hematologist/oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Pennsylvania, and Pennsylvania.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1990- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1986 - 1989
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1983 - 1986
Harvard Medical SchoolClass of 1983
Certifications & Licensure
MA State Medical License 1987 - 2027
PA State Medical License 1985 - 1986- PA State Medical License 1985 - 1986
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 22 citationsThe Protexin complex counters resection on stalled forks to promote homologous recombination and crosslink repair.Richard O. Adeyemi, Nicholas A. Willis, Andrew E. H. Elia, Connor Clairmont, Shibo Li
Molecular Cell. 2021-11-04 - 1 citationsIsolation of human and murine hematopoietic stem cells for DNA damage and DNA repair assays.Alfredo E. Rodriguez, Jessica Filiatrault, Patricia Flores-Guzmán, Hector Mayani, Kalindi Parmar
STAR Protocols. 2021-09-27 - 44 citationsA Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancerPanagiotis A. Konstantinopoulos, Alexandre André B.A. da Costa, Doga Gulhan, Elizabeth K. Lee, Su Chun Cheng
Nature Communications. 2021-09-22
Press Mentions
Dana-Farber Clinical Investigators Leverage Rich Patient Samples to Pursue Novel Cancer TherapiesDecember 3rd, 2019
Clinical Trial Underscores Promise of Immunotherapy, in Combination with Second Drug, for Ovarian CancerJuly 13th, 2019
PARI (PARPBP) Suppresses Replication Stress-Induced Myeloid Differentiation in Leukemia CellsJuly 1st, 2019- Join now to see all
